348 related articles for article (PubMed ID: 19596875)
1. Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis.
Svetitsky S; Leibovici L; Paul M
Antimicrob Agents Chemother; 2009 Oct; 53(10):4069-79. PubMed ID: 19596875
[TBL] [Abstract][Full Text] [Related]
2. Teicoplanin versus vancomycin for proven or suspected infection.
Cavalcanti AB; Goncalves AR; Almeida CS; Bugano DD; Silva E
Cochrane Database Syst Rev; 2010 Jun; (6):CD007022. PubMed ID: 20556772
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson RL; Kelsey P; Leeman H; Meardon N; Patel H; Paul K; Rees R; Taylor B; Wood E; Malakun R
Cochrane Database Syst Rev; 2011 Sep; (9):CD004610. PubMed ID: 21901692
[TBL] [Abstract][Full Text] [Related]
4. The comparative efficacy and safety of teicoplanin and vancomycin.
Wood MJ
J Antimicrob Chemother; 1996 Feb; 37(2):209-22. PubMed ID: 8707731
[TBL] [Abstract][Full Text] [Related]
5. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
Kalil AC; Murthy MH; Hermsen ED; Neto FK; Sun J; Rupp ME
Crit Care Med; 2010 Sep; 38(9):1802-8. PubMed ID: 20639754
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation.
Kato-Hayashi H; Niwa T; Ohata K; Harada S; Matsumoto T; Kitagawa J; Tsurumi H; Suzuki A
J Clin Pharm Ther; 2019 Dec; 44(6):888-894. PubMed ID: 31373043
[TBL] [Abstract][Full Text] [Related]
7. Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
Sidi V; Roilides E; Bibashi E; Gompakis N; Tsakiri A; Koliouskas D
J Chemother; 2000 Aug; 12(4):326-31. PubMed ID: 10949982
[TBL] [Abstract][Full Text] [Related]
8. Cochrane meta-analysis: teicoplanin versus vancomycin for proven or suspected infection.
Bugano DD; Cavalcanti AB; Goncalves AR; Almeida CS; Silva E
Einstein (Sao Paulo); 2011 Sep; 9(3):265-82. PubMed ID: 26761092
[TBL] [Abstract][Full Text] [Related]
9. A comparison of different antibiotic regimens for the treatment of infective endocarditis.
Martí-Carvajal AJ; Dayer M; Conterno LO; Gonzalez Garay AG; Martí-Amarista CE
Cochrane Database Syst Rev; 2020 May; 5(5):CD009880. PubMed ID: 32407558
[TBL] [Abstract][Full Text] [Related]
10. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
[TBL] [Abstract][Full Text] [Related]
11. Comparative safety of teicoplanin and vancomycin.
Wilson AP
Int J Antimicrob Agents; 1998 May; 10(2):143-52. PubMed ID: 9716291
[TBL] [Abstract][Full Text] [Related]
12. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
Paul M; Silbiger I; Grozinsky S; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2006 Jan; (1):CD003344. PubMed ID: 16437452
[TBL] [Abstract][Full Text] [Related]
13. Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.
Rybak MJ; Bailey EM; Warbasse LH
Antimicrob Agents Chemother; 1992 Jun; 36(6):1204-7. PubMed ID: 1384423
[TBL] [Abstract][Full Text] [Related]
14. β-Lactam/β-lactamase inhibitors versus carbapenems for the treatment of sepsis: systematic review and meta-analysis of randomized controlled trials.
Shiber S; Yahav D; Avni T; Leibovici L; Paul M
J Antimicrob Chemother; 2015 Jan; 70(1):41-7. PubMed ID: 25261419
[TBL] [Abstract][Full Text] [Related]
15. Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.
Van der Auwera P; Aoun M; Meunier F
Antimicrob Agents Chemother; 1991 Mar; 35(3):451-7. PubMed ID: 1828134
[TBL] [Abstract][Full Text] [Related]
16. A closer look at vancomycin, teicoplanin, and antimicrobial resistance.
Zeckel ML
J Chemother; 1997 Oct; 9(5):311-31; discussion 332-5. PubMed ID: 9373787
[TBL] [Abstract][Full Text] [Related]
17. Comparative safety of teicoplanin and vancomycin.
Wood MJ
J Chemother; 2000 Nov; 12 Suppl 5():21-5. PubMed ID: 11131960
[TBL] [Abstract][Full Text] [Related]
18. A risk-benefit assessment of teicoplanin in the treatment of infections.
de Lalla F; Tramarin A
Drug Saf; 1995 Nov; 13(5):317-28. PubMed ID: 8785019
[TBL] [Abstract][Full Text] [Related]
19. The comparative efficacy and safety of teicoplanin and vancomycin.
Cobo J; Fortún J
J Antimicrob Chemother; 1996 Dec; 38(6):1113-4. PubMed ID: 9023665
[No Abstract] [Full Text] [Related]
20. Teicoplanin as an effective alternative to vancomycin for treatment of MRSA infection in Chinese population: a meta-analysis of randomized controlled trials.
Peng Y; Ye X; Li Y; Bu T; Chen X; Bi J; Zhou J; Yao Z
PLoS One; 2013; 8(11):e79782. PubMed ID: 24260299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
